On Dec. 23, 2022, President Joe Biden signed into law the fiscal year (FY) 2023 omnibus appropriations bill. The legislation was passed by the Senate (68-29) on Dec. 22 and the House (225-201-1) on Dec. 23. The bill provides $1.7 billion in funding, $858 billion in military funding and $772 billion for domestic programs, in government funding through FY 2023. Additionally, the legislation includes a range of domestic and foreign policy priorities, including support for Ukraine, electoral reform, workplace accommodations for pregnant workers, and restrictions on the use of the social media app TikTok.
The omnibus has numerous health care provisions and policies that impact patients and companies. The omnibus package funds key health care agencies within the Department of Health and Human Services (HHS), including the National Institutes of Health (NIH), the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). The omnibus also extends telehealth flexibilities, boosts mental health funding, extends the Medicare rural hospital programs and addresses physician reimbursement rates. Additionally, the legislation delays the Medicare PAYGO sequester for two years, through the end of 2024.
Click here a detailed summary of the health care provisions included in the omnibus.
THIS DOCUMENT IS INTENDED TO PROVIDE YOU WITH GENERAL INFORMATION REGARDING THE HEALTHCARE COMPONENTS OF TH OMNIBUS BILL. THE CONTENTS OF THIS DOCUMENT ARE NOT INTENDED TO PROVIDE SPECIFIC LEGAL ADVICE. IF YOU HAVE ANY QUESTIONS ABOUT THE CONTENTS OF THIS DOCUMENT OR IF YOU NEED LEGAL ADVICE AS TO AN ISSUE, PLEASE CONTACT THE ATTORNEYS LISTED OR YOUR REGULAR BROWNSTEIN HYATT FARBER SCHRECK, LLP ATTORNEY. THIS COMMUNICATION MAY BE CONSIDERED ADVERTISING IN SOME JURISDICTIONS.
Recent Insights
Read MoreExecutive Order Tightens CBP Requirements for U.S. Importers of Record
Client Alert | June 08, 2026Can You Enforce Trade Secrets in “Vibe-Coded” Systems?
Article | June 08, 2026Data Center: Incentives, regulation or continued uncertainty
Client Alert | June 05, 2026It’s Giving … California: An Updated Roadmap for Nevada’s Anti-SLAPP Motion Practice
Client Alert | June 05, 2026USTR Requests Public Comments on the Scope and Nature of the U.S.-China Board of Trade
Client Alert | June 05, 2026Supreme Court Raises Bar for Induced Infringement in ‘Skinny Label’ Generic Case
You have chosen to send an email to Brownstein Hyatt Farber Schreck or one of its lawyers. The sending and receipt of this email and the information in it does not in itself create and attorney-client relationship between us.
If you are not already a client, you should not provide us with information that you wish to have treated as privileged or confidential without first speaking to one of our lawyers.
If you provide information before we confirm that you are a client and that we are willing and able to represent you, we may not be required to treat that information as privileged, confidential, or protected information, and we may be able to represent a party adverse to you and even to use the information you submit to us against you.
I have read this and want to send an email.